Literature DB >> 22428363

SPRIX (ketorolac tromethamine) nasal spray: a novel nonopioid alternative for managing moderate to moderately severe dental pain.

Mark B Snyder1, David B Bregmen.   

Abstract

In summary, SPRIX is a nonopioid alternative for the management of moderate to moderately severe pain. SPRIX offers dentists, physicians, and patients a new non-opioid option to control acute moderate to moderately severe pain in situations in which use of an IM or IV access is not feasible or not wanted. SPRIX is a valuable treatment option for patients with nausea or vomiting, those unable to take oral medications, and those unable to tolerate the side effects of opioids. In ambulatory acute pain settings, use of SPRIX will allow patients who need to remain alert to receive effective pain control. Currently, there are no nonopioid alternatives for the treatment of moderate to moderately severe pain other than ketorolac. In patients with more severe pain states, the combination of opioids and SPRIX provides unique advantages in maximizing analgesia while minimizing the unwanted adverse effects of both classes of drugs (referred to as multimodal or "balanced analgesia").

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428363

Source DB:  PubMed          Journal:  Compend Contin Educ Dent        ISSN: 1548-8578


  2 in total

1.  Suprachoroidal injection of ketorolac tromethamine does not cause retinal damage.

Authors:  Sumeng Liu; Wu Liu; Yaling Ma; Kegao Liu; Meizi Wang
Journal:  Neural Regen Res       Date:  2012-12-15       Impact factor: 5.135

2.  Letter to the editor.

Authors:  David B Bregman
Journal:  Sports Health       Date:  2013-03       Impact factor: 3.843

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.